Pacira Biosciences Inc
XBER:82P
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Pacira Biosciences Inc
XBER:82P
|
US |
|
G
|
Glg Life Tech Corp
F:9LTN
|
CA |
|
Sterling Check Corp
NASDAQ:STER
|
US |
|
A
|
Atlas Copco AB
F:ACO2
|
SE |
|
S
|
Sif Holding NV
F:276
|
NL |
|
I
|
Izotropic Corp
CNSX:IZO
|
CA |
|
Trulite Inc
OTC:TRUL
|
US |
|
A
|
Abb Ltd
XBER:ABJA
|
CH |
Wall St Price Targets
82P Price Targets Summary
Pacira Biosciences Inc
According to Wall Street analysts, the average 1-year price target for 82P is 33.55 EUR with a low forecast of 25.45 EUR and a high forecast of 45.7 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 82P's stock price target?
Price Target
33.55
EUR
According to Wall Street analysts, the average 1-year price target for 82P is 33.55 EUR with a low forecast of 25.45 EUR and a high forecast of 45.7 EUR.
What is the Revenue forecast for Pacira Biosciences Inc?
Projected CAGR
0%
Over the last 13 years, the compound annual growth rate for Revenue has been 25%. The projected CAGR for the next 8 years is 0%.
What is the Operating Income forecast for Pacira Biosciences Inc?
Projected CAGR
49%
The compound annual growth rate for Operating Income over the next 5 years is 49%.
What is the Net Income forecast for Pacira Biosciences Inc?
Projected CAGR
58%
The compound annual growth rate for Net Income over the next 7 years is 58%.
